drugset / Trial / NCT03968445

Neuroinflammation After Myocardial Infarction - Imaging Substudy

NCT03968445

Phase 1 Active not recruiting 6 enrolled University of Alabama at Birmingham
Non-randomizedSingle-groupOpen-labelDiagnostic

Summary

The purpose of the study is to see if positron emission tomography and magnetic resonance imaging (PET/MRI) with an investigational drug called \[18F\]DPA-714 will show inflammation in the brain after a heart attack. This study may help physicians and researchers better understand the role of brain inflammation in heart disease and develop new treatments to protect the brain.

Timeline

Start
2019-10-17
Primary completion
2028-10
Completion
2028-10

Drugs

EvaluationDrugModalityDoseRoute
Subject [18F]DPA-714 Diagnostic / imaging agent

Indications